Clinical trial
Topical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter Randomized Controlled Trial
NCT04597008 is registered in ClinicalTrials.gov with Major Extremity Trauma Research Consortium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Topical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA - A Multicenter Randomized Controlled Trial
- Lead sponsor
- Major Extremity Trauma Research Consortium
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 18, 2021
- Completion date
- July 30, 2025
- Enrollment
- 1,660 (actual)
- Sites
- 41
Conditions
As the registry lists them; a condition with its own page is linked.
post operative surgical site infection